FDA gives green light to ANDA for chewable diabetes tablet

Researchers investigated the current treatment strategies for atopic dermatitis and how they related to ideas of corticophobia among providers.

In this episode, Natalie DiPietro Mager, PharmD, PhD, speaks with Lindsay Ferraro, PharmD, associate professor of pharmacy practice at Ohio Northern University.

Patients with a single cardiometabolic disease have an approximate 48% greater risk of developing all-cause dementia compared with those without a cardiometabolic disease.

Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Brett Barker, PharmD, State Representative in Iowa’s 51st District, joined Drug Topics to discuss significant implications and common misconceptions regarding Iowa’s new PBM bill.

Efsitora demonstrates noninferior reductions in hemoglobin A1c and similar rates of patients with an A1c of less than 7% compared with common daily insulin.